Your browser doesn't support javascript.
loading
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Morrow, C J; Trapani, F; Metcalf, R L; Bertolini, G; Hodgkinson, C L; Khandelwal, G; Kelly, P; Galvin, M; Carter, L; Simpson, K L; Williamson, S; Wirth, C; Simms, N; Frankliln, L; Frese, K K; Rothwell, D G; Nonaka, D; Miller, C J; Brady, G; Blackhall, F H; Dive, C.
Affiliation
  • Morrow CJ; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Trapani F; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Metcalf RL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Bertolini G; Tumour Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Hodgkinson CL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Khandelwal G; RNA Biology Group, University of Manchester, Manchester.
  • Kelly P; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Galvin M; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Carter L; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Simpson KL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Williamson S; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Wirth C; Computational Biology Support Team, Cancer Research UK Manchester Institute, University of Manchester, Manchester.
  • Simms N; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Frankliln L; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Frese KK; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Rothwell DG; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Nonaka D; The Christie NHS Foundation Trust, Manchester.
  • Miller CJ; RNA Biology Group, University of Manchester, Manchester.
  • Brady G; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Blackhall FH; The Christie NHS Foundation Trust, Manchester; Institute of Cancer Sciences, University of Manchester, Manchester; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.
  • Dive C; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK. Electronic address: caroline.dive@cruk.manchester.ac.uk.
Ann Oncol ; 27(6): 1155-1160, 2016 06.
Article in En | MEDLINE | ID: mdl-27013395
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Carcinogenesis / Neoplastic Cells, Circulating Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Carcinogenesis / Neoplastic Cells, Circulating Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: United kingdom